Filing Details

Accession Number:
0001438133-20-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-04 16:49:13
Reporting Period:
2020-03-03
Accepted Time:
2020-03-04 16:49:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1422126 B David Berger C/O Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego CA 92121
Evp, Chief Legal & Compliance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-03 2,000 $2.59 5,311 No 4 M Direct
Common Stock Disposition 2020-03-03 2,000 $77.16 3,311 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Stock Option Stock Option Disposition 2020-03-03 2,000 $0.00 2,000 $2.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,000 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 200 Indirect Berger Family Trust
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.
  3. The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $76.95 to $77.56. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  4. The securities are held by the Berger Family Trust dated April 16, 2008.
  5. Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.
  6. The expiration date for these options is 10 years from the date of grant.